Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Debt Ratio (2017 - 2025)

Historic Debt Ratio for Ani Pharmaceuticals (ANIP) over the last 11 years, with Q3 2025 value amounting to 0.22.

  • Ani Pharmaceuticals' Debt Ratio fell 1061.97% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 1061.97%. This contributed to the annual value of 0.25 for FY2024, which is 2451.91% down from last year.
  • As of Q3 2025, Ani Pharmaceuticals' Debt Ratio stood at 0.22, which was down 1061.97% from 0.23 recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Debt Ratio registered a high of 0.43 during Q3 2021, and its lowest value of 0.22 during Q3 2025.
  • In the last 5 years, Ani Pharmaceuticals' Debt Ratio had a median value of 0.36 in 2023 and averaged 0.34.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Debt Ratio skyrocketed by 567.38% in 2021, and later plummeted by 2839.07% in 2024.
  • Over the past 5 years, Ani Pharmaceuticals' Debt Ratio (Quarter) stood at 0.37 in 2021, then increased by 1.21% to 0.38 in 2022, then decreased by 12.86% to 0.33 in 2023, then fell by 24.52% to 0.25 in 2024, then decreased by 10.37% to 0.22 in 2025.
  • Its Debt Ratio was 0.22 in Q3 2025, compared to 0.23 in Q2 2025 and 0.24 in Q1 2025.